Biomarker Research Strengthens Oncology Clinical Development
According to a new report by Polaris Market Research, the global oncology clinical trials market was valued at USD 14.21 billion in 2024 and is projected to reach USD 23.50 billion by 2034, expanding at a CAGR of 5.17% over the forecast period. Growth is underpinned by rising global cancer incidence, expanding investment in oncology drug development, and accelerating adoption of...
0 Comentários 0 Compartilhamentos 5 Visualizações 0 Anterior